Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 7/20 | 0.38 |
| ▸ | PDE2A | O00408 | 3/20 | 0.35 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.35 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.35 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11848693 | 0.84 | CYP1A2 (0.40) | PDK2PDE3BPDE3AGAALMNA | |
| SCHEMBL25337063 | 0.82 | MAOA (0.39) | OPRK1MAPK1 | |
| SCHEMBL31142492 | 0.82 | MAOA (0.39) | OPRK1MAPK1 | |
| SCHEMBL19116818 | 0.82 | NCF1 (0.45) | PDE3BPDE3AP2RY12ALKALDH1A1 | |
| SCHEMBL19105089 | 0.82 | MAOA (0.39) | OPRK1MAPK1 | |
| SCHEMBL25336502 | 0.80 | PDE3B (0.45) | PDK2PDE3BPDE3ATP53GAA | |
| SCHEMBL31142498 | 0.80 | PLA2G2A (0.39) | PDE3BPDE3AP2RY12ALDH1A1LMNA | |
| SCHEMBL10067074 | 0.79 | PDK2 (0.34) | PDK2TP53GAAEHMT2 | |
| SCHEMBL11291373 | 0.78 | MAPT (0.41) | PDK2TP53ALDH1A1EHMT2MEN1 | |
| SCHEMBL10067075 | 0.77 | PDE3B (0.35) | PDK2PDE3BPDE3AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120045851-A1 | LABELS, THEIR PRODUCTION PROCESS AND THEIR USES | LABORATOIRES SYNTH-INNOVE (FR) | 2012-02-23 | — | — | US | disclosed |
| US-8034626-B2 | Labels, their production process and their uses | LABORATOIRES SYNTH-INNOVE (FR) | 2011-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120045851-A1 | LABELS, THEIR PRODUCTION PROCESS AND THEIR USES | HLCS, PFAS, CYBA | PDK2 2168/4885PDE2A 4557/4885PDE3B 4636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.